Hardwiring tissue-specific AAV transduction in mice through engineered receptor expression.
James ZengelYu Xin WangJai Woong SeoKe NingJames N HamiltonBo WuMarina N RaieColin HolbrookShiqi SuDerek R ClementsSirika PillayAndreas S PuschnikMonte M WinslowJuliana IdoyagaClaude M NagamineYang SunVinit B MahajanKatherine W FerraraHelen M BlauJan E CarettePublished in: Nature methods (2023)
The development of transgenic mouse models that express genes of interest in specific cell types has transformed our understanding of basic biology and disease. However, generating these models is time- and resource-intensive. Here we describe a model system, SELective Expression and Controlled Transduction In Vivo (SELECTIV), that enables efficient and specific expression of transgenes by coupling adeno-associated virus (AAV) vectors with Cre-inducible overexpression of the multi-serotype AAV receptor, AAVR. We demonstrate that transgenic AAVR overexpression greatly increases the efficiency of transduction of many diverse cell types, including muscle stem cells, which are normally refractory to AAV transduction. Superior specificity is achieved by combining Cre-mediated AAVR overexpression with whole-body knockout of endogenous Aavr, which is demonstrated in heart cardiomyocytes, liver hepatocytes and cholinergic neurons. The enhanced efficacy and exquisite specificity of SELECTIV has broad utility in development of new mouse model systems and expands the use of AAV for gene delivery in vivo.
Keyphrases
- gene therapy
- mouse model
- stem cells
- poor prognosis
- cell proliferation
- cell therapy
- single cell
- transcription factor
- heart failure
- binding protein
- genome wide
- dengue virus
- gene expression
- metabolic syndrome
- dna methylation
- type diabetes
- bone marrow
- long non coding rna
- zika virus
- escherichia coli
- klebsiella pneumoniae
- drug induced
- liver injury
- wild type